Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have filed statements in court flagging concerns about vaccines.

By Puyaan Singh (Reuters) -KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a type of hereditary swelling disorder due to heavy workload and limited resources.

FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s priorities, including accelerating cures and the rapid deployment of artificial intelligence.

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

Health Secretary Robert F. Kennedy Jr. has called for a comprehensive review of nutrients and other ingredients, such as heavy metals, in infant formula.

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns about the abortion pill's safety are misguided.

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.

The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s been significantly impacted by the recent changes in FDA and HHS leadership.

Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday announced eight members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, populated mainly by critics of the nation’s COVID-19 vaccine policies or those who don’t specialize in vaccine science.